» Articles » PMID: 38549547

Interdialytic Home Systolic Blood Pressure Variability Increases All-cause Mortality in Hemodialysis Patients

Overview
Journal Clin Cardiol
Date 2024 Mar 29
PMID 38549547
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The association between Interdialytic home blood pressure variability (BPV) and the prognosis of patients undergoing maintenance hemodialysis (MHD) largely unknown.

Hypothesis: We proposed the hypothesis that interdialytic home BPV exert effect on cardiac and all-cause mortality among individuals undergoing MHD.

Methods: A total of 158 patients receiving MHD at the hemodialysis unit of Wuhan Fourth Hospital between December 2019 and August 2020 were included in this prospective cohort study. Patients were divided into tertiles according to the systolic BPV (SBPV), and the primary endpoints were cardiac and all-cause death. Kaplan-Meier analysis was used to assess the relationship between long-term survival and interdialytic home SBPV. In addition, Cox proportional hazards regression models were used to identify risk factors contributing to poor prognosis.

Results: The risk of cardiac death and all-cause death was gradually increased in patients according to tertiles of SBPV (3.5% vs. 14.8% vs. 19.2%, p for trend = .021; and 11.5% vs. 27.8% vs. 44.2%, p for trend <.001). The Cox regression analysis revealed that compared to Tertile 1, the hazard ratios for all-cause mortality in Tertile 2 and Tertile 3 were 3.13 (p = .026) and 3.24 (p = .021), respectively, after adjustment for a series of covariates.

Conclusions: The findings revealed a positive correlation between increased interdialytic home SBPV and elevated mortality risk in patients with MHD.

Citing Articles

How to demonstrate the prognostic impact of interdialytic home blood pressure variability in dialytic patients.

Marubayashi N, Kakeshita K, Imamura T Clin Cardiol. 2024; 47(5):e24279.

PMID: 38775272 PMC: 11110098. DOI: 10.1002/clc.24279.


Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end-stage kidney disease patients undergoing hemodialysis.

Lee S, Chao C Clin Cardiol. 2024; 47(5):e24281.

PMID: 38738580 PMC: 11089592. DOI: 10.1002/clc.24281.


Interdialytic home systolic blood pressure variability increases all-cause mortality in hemodialysis patients.

Dong L, Tian M, Li H, Dong J, Song X Clin Cardiol. 2024; 47(4):e24259.

PMID: 38549547 PMC: 10979187. DOI: 10.1002/clc.24259.

References
1.
Mena L, Pintos S, Queipo N, Aizpurua J, Maestre G, Sulbaran T . A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005; 23(3):505-11. DOI: 10.1097/01.hjh.0000160205.81652.5a. View

2.
Maruyama T, Takashima H, Abe M . Blood pressure targets and pharmacotherapy for hypertensive patients on hemodialysis. Expert Opin Pharmacother. 2020; 21(10):1219-1240. DOI: 10.1080/14656566.2020.1746272. View

3.
Rothwell P, Howard S, Dolan E, OBrien E, Dobson J, Dahlof B . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375(9718):895-905. DOI: 10.1016/S0140-6736(10)60308-X. View

4.
Parati G, Ochoa J, Bilo G, Agarwal R, Covic A, Dekker F . Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles. Hypertension. 2016; 67(6):1102-10. DOI: 10.1161/HYPERTENSIONAHA.115.06896. View

5.
Parati G, Ochoa J, Lombardi C, Bilo G . Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013; 10(3):143-55. DOI: 10.1038/nrcardio.2013.1. View